Clorox (CLX) EBIT Margin (2009 - 2026)

Clorox's EBIT Margin history runs 18 years deep, the most recent figure standing at 27.9% for Q1 2026.

• On a quarterly basis, EBIT Margin rose 93.0% year-over-year to 27.9% in Q1 2026; TTM through Mar 2026 was 26.39%, a 146.0% decrease from a year earlier, with the FY2025 full-year figure at 27.7%, up 296.0% from the prior year.
• EBIT Margin grew to 27.9% in Q1 2026 per CLX's latest filing, from 25.76% in the prior quarter.
• Across five years, EBIT Margin topped out at 30.64% in Q2 2024 and bottomed at 16.38% in Q3 2023.
• The 5-year median for EBIT Margin is 24.52% (2023), against an average of 24.06%.
• Across the five-year window, EBIT Margin surged 1172 bps in 2024 and tumbled 773 bps in 2025, its largest moves.
• Year by year, EBIT Margin stood at 17.78% in 2022, then soared by 45 bps to 25.73% in 2023, then fell by 2 bps to 25.33% in 2024, then rose by 2 bps to 25.76% in 2025, then increased by 8 bps to 27.9% in 2026.
• Per Business Quant, the three latest CLX EBIT Margin figures stand at 27.9% (Q1 2026), 25.76% (Q4 2025), and 20.36% (Q3 2025).